{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:46:34Z","timestamp":1790243194641,"version":"4.1.0"},"reference-count":150,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T00:00:00Z","timestamp":1522108800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SE 2665\/1-1, SFB841 and KFO306"],"award-info":[{"award-number":["SE 2665\/1-1, SFB841 and KFO306"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.00609","type":"journal-article","created":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T00:21:49Z","timestamp":1522110109000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":133,"title":["Autoantibodies in Autoimmune Liver Disease\u2014Clinical and Diagnostic Relevance"],"prefix":"10.3389","volume":"9","author":[{"given":"Marcial","family":"Sebode","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Weiler-Normann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timur","family":"Liwinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Schramm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,3,27]]},"reference":[{"key":"B1","first-page":"971","article-title":"EASL clinical practice guidelines: autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J Heatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"EASL clinical practice guidelines: the diagnosis and management of patients with primary biliary cholangitis","volume":"67","year":"2017","journal-title":"J Hepatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1136\/gutjnl-2016-311739","article-title":"Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis","volume":"66","author":"Jendrek","year":"2017","journal-title":"Gut"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jhep.2015.03.005","article-title":"Autoimmune hepatitis \u2013 update 2015","volume":"62","author":"Manns","year":"2015","journal-title":"J Hepatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1002\/hep.1840180435","article-title":"Meeting report: international autoimmune hepatitis group","volume":"18","author":"Johnson","year":"1993","journal-title":"Hepatology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.jhep.2004.08.002","article-title":"Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the international autoimmune hepatitis group","volume":"41","author":"Vergani","year":"2004","journal-title":"J Hepatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1002\/art.1780400909","article-title":"Range of antinuclear antibodies in \u201chealthy\u201d individuals","volume":"40","author":"Tan","year":"1997","journal-title":"Arthritis Rheum"},{"key":"B11","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/hep.26666","article-title":"Antismooth muscle and antiactin antibodies are indirect markers of histological and biochemical activity of autoimmune hepatitis","volume":"59","author":"Couto","year":"2014","journal-title":"Hepatology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1002\/hep.1840070626","article-title":"Chronic active hepatitis associated with antiliver\/kidney microsome antibody type 1: a second type of \u201cautoimmune\u201d hepatitis","volume":"7","author":"Homberg","year":"1987","journal-title":"Hepatology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1002\/hep.1840080632","article-title":"Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2","volume":"8","author":"Martini","year":"1988","journal-title":"Hepatology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/0016-5085(95)90074-8","article-title":"Heterogeneity of liver-kidney microsomal autoantibodies in chronic hepatitis C and D virus infection","volume":"108","author":"Durazzo","year":"1995","journal-title":"Gastroenterology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/hep.510250308","article-title":"Autoimmune hepatitis in childhood: a 20-year experience","volume":"25","author":"Gregorio","year":"1997","journal-title":"Hepatology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0168-8278(99)80342-0","article-title":"Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis","volume":"31","author":"Kanzler","year":"1999","journal-title":"J Hepatol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/S0168-8278(00)80361-X","article-title":"Antibodies to soluble liver antigen: an additional marker in type 1 auto-immune hepatitis","volume":"33","author":"Ballot","year":"2000","journal-title":"J Hepatol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1572-0241.2002.05479.x","article-title":"Antibodies to soluble liver antigen\/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis","volume":"97","author":"Czaja","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1002\/hep.27983","article-title":"Prediction of short- and long-term outcome in patients with autoimmune hepatitis","volume":"62","author":"Kirstein","year":"2015","journal-title":"Hepatology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/S0140-6736(87)92024-1","article-title":"Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen","volume":"1","author":"Manns","year":"1987","journal-title":"Lancet"},{"key":"B21","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/MPG.0000000000001801","article-title":"Diagnosis and management of paediatric autoimmune liver disease: ESPGHAN hepatology committee position statement","volume":"66","author":"Mieli-Vergani","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B22","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1080\/0891693021000056721","article-title":"Organ and non-organ specific autoantibody titres and IgG levels as markers of disease activity: a longitudinal study in childhood autoimmune liver disease","volume":"35","author":"Gregorio","year":"2002","journal-title":"Autoimmunity"},{"key":"B23","first-page":"1323","article-title":"Lupoid hepatitis","volume":"271","author":"Cowling","year":"1956","journal-title":"Lancet"},{"key":"B24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jaut.2013.08.001","article-title":"Clinical significance of autoantibodies in autoimmune hepatitis","volume":"46","author":"Liberal","year":"2013","journal-title":"J Autoimmun"},{"key":"B25","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/0016-5085(94)90078-7","article-title":"Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis","volume":"107","author":"Czaja","year":"1994","journal-title":"Gastroenterology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1016\/S0016-5085(96)70020-3","article-title":"Autoantibodies against glucuronosyltransferases differ between viral hepatitis and autoimmune hepatitis","volume":"111","author":"Strassburg","year":"1996","journal-title":"Gastroenterology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/S0168-8278(96)80290-X","article-title":"Identification of cyclin A as a molecular target of antinuclear antibodies (ANA) in hepatic and non-hepatic autoimmune diseases","volume":"25","author":"Strassburg","year":"1996","journal-title":"J Hepatol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/hep.510260306","article-title":"Antibodies to single-stranded and double-stranded DNA in antinuclear antibody-positive type 1-autoimmune hepatitis","volume":"26","author":"Czaja","year":"1997","journal-title":"Hepatology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1023\/A:1018880429469","article-title":"Antibodies to Ro\/La, Cenp-B, and snRNPs antigens in autoimmune hepatitis of North America versus Asia: patterns of immunofluorescence, ELISA reactivities, and HLA association","volume":"43","author":"Parveen","year":"1998","journal-title":"Dig Dis Sci"},{"key":"B30","doi-asserted-by":"publisher","first-page":"12662","DOI":"10.3748\/wjg.v20.i35.12662","article-title":"Association of autoimmune hepatitis and systemic lupus erythematodes: a case series and review of the literature","volume":"20","author":"Beisel","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B31","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0016-5085(19)34365-3","article-title":"Smooth muscle autoantibody in \u201cautoimmune\u201d hepatitis","volume":"51","author":"Whittingham","year":"1966","journal-title":"Gastroenterology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1097\/01.mcg.0000139072.38580.a0","article-title":"Prevalence and significance of autoantibodies in patients with non-alcoholic steatohepatitis","volume":"38","author":"Cotler","year":"2004","journal-title":"J Clin Gastroenterol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1080\/0891693021000054066","article-title":"Smooth muscle antibodies and type 1 autoimmune hepatitis","volume":"35","author":"Muratori","year":"2002","journal-title":"Autoimmunity"},{"key":"B34","first-page":"621","article-title":"Smooth muscle autoantibodies and autoantigens","volume":"38","author":"Toh","year":"1979","journal-title":"Clin Exp Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1600-0676.1983.tb00890.x","article-title":"Anti-actin antibodies of IgM and IgG class in chronic liver diseases detected by fluorometric immunoassay","volume":"3","author":"Wiedmann","year":"1983","journal-title":"Liver"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1111\/j.1572-0241.2006.00830.x","article-title":"Evaluation of F-actin ELISA for the diagnosis of autoimmune hepatitis","volume":"101","author":"Frenzel","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1136\/jcp.2006.039404","article-title":"Diagnostic relevance of anti-filamentous actin antibodies in autoimmune hepatitis","volume":"60","author":"Liaskos","year":"2007","journal-title":"J Clin Pathol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/0016-5085(92)91518-9","article-title":"Frequency and significance of antibodies to liver\/kidney microsome type 1 in adults with chronic active hepatitis","volume":"103","author":"Czaja","year":"1992","journal-title":"Gastroenterology"},{"key":"B39","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1136\/jcp.55.12.906","article-title":"Detection of liver kidney microsomal type 1 antibody using molecularly based immunoassays","volume":"55","author":"Kerkar","year":"2002","journal-title":"J Clin Pathol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1084\/jem.168.2.801","article-title":"Anti-liver kidney microsome antibody recognizes a cytochrome P450 from the IID subfamily","volume":"168","author":"Gueguen","year":"1988","journal-title":"J Exp Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1172\/JCI113949","article-title":"Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1","volume":"83","author":"Manns","year":"1989","journal-title":"J Clin Invest"},{"key":"B42","doi-asserted-by":"publisher","first-page":"8256","DOI":"10.1073\/pnas.85.21.8256","article-title":"Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II","volume":"85","author":"Zanger","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1172\/JCI115443","article-title":"LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase","volume":"88","author":"Manns","year":"1991","journal-title":"J Clin Invest"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1002\/eji.1830230519","article-title":"Identification and analysis of cytochrome P450IID6 antigenic sites recognized by anti-liver-kidney microsome type-1 antibodies (LKM1)","volume":"23","author":"Yamamoto","year":"1993","journal-title":"Eur J Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S0168-8278(96)80228-5","article-title":"Non-organ specific autoantibodies in children with chronic hepatitis C","volume":"25","author":"Bortolotti","year":"1996","journal-title":"J Hepatol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/S0168-8278(97)80107-9","article-title":"Frequency and significance of antibodies to P450IID6 protein in Japanese patients with chronic hepatitis C","volume":"26","author":"Nishioka","year":"1997","journal-title":"J Hepatol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/0016-5085(95)90076-4","article-title":"Conformational epitopes on CYP2D6 are recognized by liver\/kidney microsomal antibodies","volume":"108","author":"Duclos-Vallee","year":"1995","journal-title":"Gastroenterology"},{"key":"B48","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1046\/j.1365-2249.1999.01027.x","article-title":"Overlapping but distinct specificities of anti-liver-kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes","volume":"118","author":"Klein","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1073\/pnas.84.2.551","article-title":"Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug","volume":"84","author":"Beaune","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B50","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/S0140-6736(94)91966-6","article-title":"Recognition of uridine diphosphate glucuronosyl transferases by LKM-3 antibodies in chronic hepatitis D","volume":"344","author":"Philipp","year":"1994","journal-title":"Lancet"},{"key":"B51","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1111\/j.1572-0241.2001.03383.x","article-title":"LKM3 autoantibodies in hepatitis C cirrhosis: a further phenomenon of the HCV-induced autoimmunity","volume":"96","author":"Csepregi","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1136\/gut.51.2.259","article-title":"Establishment of standardised SLA\/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics","volume":"51","author":"Baeres","year":"2002","journal-title":"Gut"},{"key":"B53","first-page":"921","article-title":"Hypergammaglobulin\u00e4mische chronisch aktive Hepatitis mit Nachweis von Leber-Pankreas-spezifischen komplementbindenden Antik\u00f6rpern","volume":"87","author":"Berg","year":"1981","journal-title":"Verh Dtsch Ges Inn Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"9739","DOI":"10.1073\/pnas.89.20.9739","article-title":"Autoantibodies against a serine tRNA-protein complex implicated in cotranslational selenocysteine insertion","volume":"89","author":"Gelpi","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/hep.1840180102","article-title":"Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis","volume":"18","author":"Stechemesser","year":"1993","journal-title":"Hepatology"},{"key":"B56","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1046\/j.1365-2249.2000.01280.x","article-title":"Isolation and characterization of cDNA encoding the antigenic protein of the human tRNP(Ser)Sec complex recognized by autoantibodies from patients withtype-1 autoimmune hepatitis","volume":"121","author":"Costa","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1016\/S0140-6736(00)02166-8","article-title":"Identification of target antigen for SLA\/LP autoantibodies in autoimmune hepatitis","volume":"355","author":"Wies","year":"2000","journal-title":"Lancet"},{"key":"B58","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1053\/jhep.2001.22218","article-title":"Soluble liver antigen: isolation of a 35-kd recombinant protein (SLA-p35) specifically recognizing sera from patients with autoimmune hepatitis","volume":"33","author":"Volkmann","year":"2001","journal-title":"Hepatology"},{"key":"B59","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1053\/jhep.2002.30699","article-title":"Fine specificity of autoantibodies to soluble liver antigen and liver\/pancreas","volume":"35","author":"Herkel","year":"2002","journal-title":"Hepatology"},{"key":"B60","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1053\/j.gastro.2008.07.029","article-title":"Identification of CD4 T-cell epitopes in soluble liver antigen\/liver pancreas autoantigen in autoimmune hepatitis","volume":"135","author":"Mix","year":"2008","journal-title":"Gastroenterology"},{"key":"B61","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/liv.12658","article-title":"Anti-SLA\/LP alone or in combination with anti-Ro52 and fine specificity of anti-Ro52 antibodies in patients with autoimmune hepatitis","volume":"35","author":"Zachou","year":"2015","journal-title":"Liver Int"},{"key":"B62","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/j.1572-0241.2006.00479.x","article-title":"Pregnancy in autoimmune hepatitis: outcome and risk factors","volume":"101","author":"Schramm","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0016-5085(99)70186-1","article-title":"Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis","volume":"116","author":"Lapierre","year":"1999","journal-title":"Gastroenterology"},{"key":"B64","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1136\/gut.36.5.749","article-title":"Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection","volume":"36","author":"Lenzi","year":"1995","journal-title":"Gut"},{"key":"B65","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/0022-1759(95)00192-X","article-title":"Detection of anti-liver cytosol antibody type 1 (anti-LC1) by immunodiffusion, counterimmunoelectrophoresis and immunoblotting: comparison of different techniques","volume":"187","author":"Muratori","year":"1995","journal-title":"J Immunol Methods"},{"key":"B66","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/S0168-8278(05)80508-2","article-title":"Anti-neutrophil antibodies in chronic viral hepatitis","volume":"20","author":"Dalekos","year":"1994","journal-title":"J Hepatol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.3748\/wjg.v13.i14.2028","article-title":"Utility of serological markers in inflammatory bowel diseases: gadget or magic?","volume":"13","author":"Papp","year":"2007","journal-title":"World J Gastroenterol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/liv.13238","article-title":"Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis","volume":"37","author":"Hov","year":"2017","journal-title":"Liver Int"},{"key":"B69","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s12016-017-8616-5","article-title":"Cutaneous manifestations of ANCA-associated small vessels vasculitis","volume":"53","author":"Marzano","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.autrev.2012.04.005","article-title":"Asialoglycoprotein receptor (ASGPR) as target autoantigen in liver autoimmunity: lost and found","volume":"12","author":"Rigopoulou","year":"2012","journal-title":"Autoimmun Rev"},{"key":"B71","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/hep.22380","article-title":"Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis","volume":"48","author":"O\u2019Brien","year":"2008","journal-title":"Hepatology"},{"key":"B72","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.cgh.2012.02.010","article-title":"Patients with autoimmune hepatitis who have antimitochondrial antibodies need longterm follow-up to detect late development of primary biliary cirrhosis","volume":"10","author":"Dinani","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1002\/hep.21828","article-title":"Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosis","volume":"46","author":"Leung","year":"2007","journal-title":"Hepatology"},{"key":"B74","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1136\/gut.46.4.553","article-title":"Liver\/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane","volume":"46","author":"Muratori","year":"2000","journal-title":"Gut"},{"key":"B75","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1053\/j.gastro.2005.12.020","article-title":"Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2","volume":"130","author":"Ma","year":"2006","journal-title":"Gastroenterology"},{"key":"B76","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/hep.21658","article-title":"Cytochrome P450IID6-specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2","volume":"46","author":"Longhi","year":"2007","journal-title":"Hepatology"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1002\/hep.1840120611","article-title":"The human hepatic asialoglycoprotein receptor is a target antigen for liver-infiltrating T cells in autoimmune chronic active hepatitis and primary biliary cirrhosis","volume":"12","author":"L\u00f6hr","year":"1990","journal-title":"Hepatology"},{"key":"B78","volume-title":"Etude sur une Forme de Cirrhose Hypertrophique du Foie (Cirrhose Hypertrophique ave ictere chronique)","author":"Hanot","year":"1876"},{"key":"B79","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S1089-3261(03)00098-9","article-title":"Primary biliary cirrhosis: historical perspective","volume":"7","author":"Heathcote","year":"2003","journal-title":"Clin Liver Dis"},{"key":"B80","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/S0140-6736(65)91372-3","article-title":"Serological tests in diagnosis of primary biliary cirrhosis","volume":"1","author":"Walker","year":"1965","journal-title":"Lancet"},{"key":"B81","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41598-017-00906-1","article-title":"Detection of AMA-M2 in human saliva: potentials in diagnosis and monitoring of primary biliary cholangitis","volume":"7","author":"Lu","year":"2017","journal-title":"Sci Rep"},{"key":"B82","doi-asserted-by":"publisher","first-page":"e007985","DOI":"10.1136\/bmjopen-2015-007985","article-title":"RITPBC: B-cell depleting therapy (rituximab) as a treatment for fatigue in primary biliary cirrhosis: study protocol for a randomised controlled trial","volume":"5","author":"Jopson","year":"2015","journal-title":"BMJ Open"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1055\/s-0043-120199","article-title":"[Practice guideline autoimmune liver diseases \u2013 AWMF-Reg. No. 021-27]","volume":"55","year":"2017","journal-title":"Z Gastroenterol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.cld.2008.02.009","article-title":"Antimitochondrial antibodies and other antibodies in primary biliary cirrhosis: diagnostic and prognostic value","volume":"12","author":"Muratori","year":"2008","journal-title":"Clin Liver Dis"},{"key":"B85","doi-asserted-by":"publisher","first-page":"973","DOI":"10.3748\/wjg.v16.i8.973","article-title":"Catalytic domain of PDC-E2 contains epitopes recognized by antimitochondrial antibodies in primary biliary cirrhosis","volume":"16","author":"Braun","year":"2010","journal-title":"World J Gastroenterol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1365-2249.2004.02332.x","article-title":"\u2018True\u2019 antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both?","volume":"135","author":"Muratori","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jaut.2009.08.009","article-title":"A comprehensive evaluation of serum autoantibodies in primary biliary cirrhosis","volume":"34","author":"Agmon-Levin","year":"2010","journal-title":"J Autoimmun"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/S0140-6736(82)91327-7","article-title":"ATPase-associated antigen (M2): marker antigen for serological diagnosis of primary biliary cirrhosis","volume":"2","author":"Berg","year":"1982","journal-title":"Lancet"},{"key":"B89","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.4049\/jimmunol.138.10.3525","article-title":"Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis","volume":"138","author":"Gershwin","year":"1987","journal-title":"J Immunol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s12072-012-9413-0","article-title":"Humoral autoimmune response heterogeneity in the spectrum of primary biliary cirrhosis","volume":"7","author":"Dellavance","year":"2012","journal-title":"Hepatol Int"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/S0140-6736(96)04410-8","article-title":"Natural history of early primary biliary cirrhosis","volume":"348","author":"Metcalf","year":"1996","journal-title":"Lancet"},{"key":"B92","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/hep.28859","article-title":"Large-scale characterization study of patients with antimitochondrial antibodies but nonestablished primary biliary cholangitis","volume":"65","author":"Dahlqvist","year":"2017","journal-title":"Hepatology"},{"key":"B93","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/hep.510240117","article-title":"Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies","volume":"24","author":"Moteki","year":"1996","journal-title":"Hepatology"},{"key":"B94","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1196\/annals.1381.028","article-title":"The clinical significance of IgA antimitochondrial antibodies in sera and saliva in primary biliary cirrhosis","volume":"1107","author":"Tanaka","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"B95","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/hep.1840080217","article-title":"The predominance of IgG3 and IgM isotype antimitochondrial autoantibodies against recombinant fused mitochondrial polypeptide in patients with primary biliary cirrhosis","volume":"8","author":"Surh","year":"1988","journal-title":"Hepatology"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1111\/j.1478-3231.2007.01586.x","article-title":"Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis","volume":"27","author":"Rigopoulou","year":"2007","journal-title":"Liver Int"},{"key":"B97","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1309\/AJCPQV4A7QAEEFEV","article-title":"The significance of autoantibody changes over time in primary biliary cirrhosis","volume":"144","author":"Tana","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1055\/s-2005-916321","article-title":"Antinuclear antibodies in primary biliary cirrhosis","volume":"25","author":"Invernizzi","year":"2005","journal-title":"Semin Liver Dis"},{"key":"B99","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/hep.21472","article-title":"Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis","volume":"45","author":"Nakamura","year":"2007","journal-title":"Hepatology"},{"key":"B100","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.4049\/jimmunol.145.12.4338","article-title":"Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis","volume":"145","author":"Szostecki","year":"1990","journal-title":"J Immunol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1080\/15321819.2012.741088","article-title":"Detection of anti-SP100 antibodies in primary biliary cirrhosis. Comparison of ELISA and immunofluorescence","volume":"34","author":"Bauer","year":"2013","journal-title":"J Immunoassay Immunochem"},{"key":"B102","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1172\/JCI114696","article-title":"The 210-kD nuclear envelope polypeptide recognized by human autoantibodies in primary biliary cirrhosis is the major glycoprotein of the nuclear pore","volume":"86","author":"Courvalin","year":"1990","journal-title":"J Clin Invest"},{"key":"B103","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1084\/jem.172.3.961","article-title":"Identification and characterization of autoantibodies against the nuclear envelope lamin B receptor from patients with primary biliary cirrhosis","volume":"172","author":"Courvalin","year":"1990","journal-title":"J Exp Med"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1002\/hep.21172","article-title":"Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis","volume":"43","author":"Wesierska-Gadek","year":"2006","journal-title":"Hepatology"},{"key":"B105","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/apt.13927","article-title":"The risk predictive values of UK-PBC and GLOBE scoring system in Chinese patients with primary biliary cholangitis: the additional effect of anti-gp210","volume":"45","author":"Yang","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"B106","doi-asserted-by":"publisher","first-page":"4938","DOI":"10.3748\/wjg.v16.i39.4938","article-title":"Peri-nuclear antibodies correlate with survival in Greek primary biliary cirrhosis patients","volume":"16","author":"Sfakianaki","year":"2010","journal-title":"World J Gastroenterol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.clinre.2013.04.005","article-title":"Diagnostic and clinical significance of anti-centromere antibodies in primary biliary cirrhosis","volume":"37","author":"Liberal","year":"2013","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1111\/hepr.12461","article-title":"Anti-gp210 and anti-centromere antibodies for the prediction of PBC patients with an incomplete biochemical response to UDCA and bezafibrate","volume":"45","author":"Honda","year":"2015","journal-title":"Hepatol Res"},{"key":"B109","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s10157-012-0724-1","article-title":"Anti-centromere antibody is an independent risk factor for chronic kidney disease in patients with primary biliary cirrhosis","volume":"17","author":"Mandai","year":"2013","journal-title":"Clin Exp Nephrol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/liv.12690","article-title":"Anti-kelch-like 12 and anti-hexokinase 1: novel autoantibodies in primary biliary cirrhosis","volume":"35","author":"Norman","year":"2015","journal-title":"Liver Int"},{"key":"B111","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/hep.510280203","article-title":"Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy","volume":"28","author":"Chazouilleres","year":"1998","journal-title":"Hepatology"},{"key":"B112","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/j.1478-3231.2009.01986.x","article-title":"Significance of antibodies to soluble liver antigen\/liver pancreas: a large French study","volume":"29","author":"Eyraud","year":"2009","journal-title":"Liver Int"},{"key":"B113","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1055\/s-2001-12906","article-title":"Presence of SLA\/LP autoantibodies in patients with primary biliary cirrhosis as a marker for secondary autoimmune hepatitis (overlap syndrome)","volume":"126","author":"Kanzler","year":"2001","journal-title":"Dtsch Med Wochenschr"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1038\/ajg.2009.126","article-title":"The serological profile of the autoimmune hepatitis\/primary biliary cirrhosis overlap syndrome","volume":"104","author":"Muratori","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","article-title":"Primary sclerosing cholangitis \u2013 a comprehensive review","volume":"67","author":"Karlsen","year":"2017","journal-title":"J Hepatol"},{"key":"B116","first-page":"23","article-title":"Primary sclerosing cholangitis \u2013 a study of forty-two cases","volume":"111","author":"Warren","year":"1966","journal-title":"Gut"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/S0140-6736(13)60096-3","article-title":"Primary sclerosing cholangitis","volume":"382","author":"Hirschfield","year":"2013","journal-title":"Lancet"},{"key":"B118","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/MOG.0000000000000333","article-title":"The evolution of natural history of primary sclerosing cholangitis","volume":"33","author":"Takakura","year":"2017","journal-title":"Curr Opin Gastroenterol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1002\/hep.26565","article-title":"Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis","volume":"58","author":"Boonstra","year":"2013","journal-title":"Hepatology"},{"key":"B120","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1572-0241.2006.00872.x","article-title":"Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: a single center study","volume":"102","author":"Tischendorf","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1148\/radiol.10091953","article-title":"Primary sclerosing cholangitis: meta-analysis of diagnostic performance of MR cholangiopancreatography","volume":"256","author":"Dave","year":"2010","journal-title":"Radiology"},{"key":"B122","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1111\/j.1572-0241.2003.07401.x","article-title":"Is there a role for liver biopsy in primary sclerosing cholangitis?","volume":"98","author":"Burak","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1056\/NEJMra1506330","article-title":"Primary sclerosing cholangitis","volume":"375","author":"Lazaridis","year":"2016","journal-title":"N Engl J Med"},{"key":"B124","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/ajg.2015.112","article-title":"ACG clinical guideline: primary sclerosing cholangitis","volume":"110","author":"Lindor","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"B125","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL clinical practice guidelines: management of cholestatic liver diseases","volume":"51","year":"2009","journal-title":"J Hepatol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.3748\/wjg.14.3781","article-title":"Autoantibodies in primary sclerosing cholangitis","volume":"14","author":"Hov","year":"2008","journal-title":"World J Gastroenterol"},{"key":"B127","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/S0168-8278(00)80241-X","article-title":"Clinical significance of anti-neutrophil cytoplasmic autoimmune liver diseases antibodies (ANCA) in autoimmune liver diseases","volume":"32","author":"Roozendaal","year":"2000","journal-title":"J Hepatol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/hep.510280207","article-title":"Atypical antineutrophil cytoplasmic antibodies with perinuclear fluorescence in chronic inflammatory bowel diseases and hepatobiliary disorders colocalize with nuclear lamina proteins","volume":"28","author":"Terjung","year":"1998","journal-title":"Hepatology"},{"key":"B129","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s12016-008-8088-8","article-title":"Atypical p-ANCA in PSC and AIH: a hint toward a \u201cleaky gut\u201d?","volume":"36","author":"Terjung","year":"2009","journal-title":"Clin Rev Allergy Immunol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1053\/gast.2000.9366","article-title":"\u201cAtypical p-ANCA\u201d in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines","volume":"119","author":"Terjung","year":"2000","journal-title":"Gastroenterology"},{"key":"B131","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1046\/j.1365-2249.2001.01649.x","article-title":"Differentiation of antineutrophil nuclear antibodies in inflammatory bowel and autoimmune liver diseases from antineutrophil cytoplasmic antibodies (p-ANCA) using immunofluorescence microscopy","volume":"126","author":"Terjung","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1136\/gut.2008.157818","article-title":"p-ANCAs in autoimmune liver disorders recognise human beta-tubulin isotype 5 and cross-react with microbial protein FtsZ","volume":"59","author":"Terjung","year":"2010","journal-title":"Gut"},{"key":"B133","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.3109\/00365521.2013.825313","article-title":"Scandinavian journal of gastroenterology antineutrophil cytoplasmic antibodies in bile are associated with disease activity in primary sclerosing cholangitis","volume":"48","author":"Lenzen","year":"2013","journal-title":"Scand J Gastroenterol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1440-1746.1994.tb01214.x","article-title":"Anti-neutrophil cytoplasmic antibody: a prognostic indicator in primary sclerosing cholangitis","volume":"9","author":"Pokorny","year":"1994","journal-title":"J Gastroenterol Hepatol"},{"key":"B135","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/S0168-8278(05)80604-X","article-title":"A 2-year follow-up study of anti-neutrophil antibody in primary sclerosing cholangitis: relationship to clinical activity, liver biochemistry and ursodeoxycholic acid treatment","volume":"21","author":"Lo","year":"1994","journal-title":"J Hepatol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1053\/j.gastro.2008.11.033","article-title":"Antineutrophil cytoplasmic antibodies in small-duct primary sclerosing cholangitis","volume":"136","author":"Tervaert","year":"2009","journal-title":"Gastroenterology"},{"key":"B137","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1136\/gut.51.1.120","article-title":"High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6","volume":"51","author":"Xu","year":"2002","journal-title":"Gut"},{"key":"B138","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0016-5085(94)95271-X","article-title":"Autoantibodies in sclerosing cholangitis against a shared peptide in biliary and colon epithelium","volume":"106","author":"Mandal","year":"1994","journal-title":"Gastroenterology"},{"key":"B139","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1053\/j.gastro.2007.01.039","article-title":"Biliary epithelial cell antibodies link adaptive and innate immune responses in primary sclerosing cholangitis","volume":"132","author":"Karrar","year":"2007","journal-title":"Gastroenterology"},{"key":"B140","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3109\/00365521.2013.786131","article-title":"Primary sclerosing cholangitis is associated with autoreactive IgA antibodies against biliary epithelial cells","volume":"48","author":"Berglin","year":"2013","journal-title":"Scand J Gastroenterol"},{"key":"B141","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1034\/j.1600-0641.2000.033004537.x","article-title":"Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system","volume":"33","author":"Kaya","year":"2000","journal-title":"J Hepatol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study","volume":"33","author":"Gregorio","year":"2001","journal-title":"Hepatology"},{"key":"B143","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1053\/jhep.2003.50289","article-title":"Primary sclerosing cholangitis in children: a long-term follow-up study","volume":"38","author":"Feldstein","year":"2003","journal-title":"Hepatology"},{"key":"B144","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/ecco-jcc\/jjv087","article-title":"Rediscovery of the anti-pancreatic antibodies and evaluation of their prognostic value in a prospective clinical cohort of Crohn\u2019s patients: the importance of specific target antigens [GP2 and CUZD1]","volume":"9","author":"Papp","year":"2015","journal-title":"J Crohns Colitis"},{"key":"B145","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1471-230X-9-58","article-title":"The pancreatic zymogen granule membrane protein, GP2, binds Escherichia coli type 1 fimbriae","volume":"9","author":"Yu","year":"2009","journal-title":"BMC Gastroenterol"},{"key":"B146","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature08529","article-title":"Uptake through glycoprotein 2 of FimH + bacteria by M cells initiates mucosal immune response","volume":"462","author":"Hase","year":"2009","journal-title":"Nature"},{"key":"B147","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1136\/gutjnl-2015-310500","article-title":"The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls","volume":"66","author":"Kummen","year":"2017","journal-title":"Gut"},{"key":"B148","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1136\/gutjnl-2016-312180","article-title":"Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis","volume":"66","author":"R\u00fchlemann","year":"2017","journal-title":"Gut"},{"key":"B149","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1136\/gutjnl-2015-311004","article-title":"Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD","volume":"65","author":"Sabino","year":"2016","journal-title":"Gut"},{"key":"B150","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1111\/j.1572-0241.2006.00772.x","article-title":"Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis","volume":"101","author":"Mendes","year":"2006","journal-title":"Am J Gastroenterol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00609\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T06:12:29Z","timestamp":1719900749000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00609\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,27]]},"references-count":150,"alternative-id":["10.3389\/fimmu.2018.00609"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.00609","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,27]]},"article-number":"609"}}